1. Home
  2. TENX vs ANTA Comparison

TENX vs ANTA Comparison

Compare TENX & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.48

Market Cap

73.8M

Sector

Health Care

ML Signal

N/A

Logo Antalpha Platform Holding Company Ordinary Shares

ANTA

Antalpha Platform Holding Company Ordinary Shares

SELL

Current Price

$2.19

Market Cap

68.2M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TENX
ANTA
Founded
1967
2022
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.8M
68.2M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
TENX
ANTA
Price
$1.48
$2.19
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
★ $10.29
$8.25
AVG Volume (30 Days)
★ 1.4M
16.2K
Earning Date
11-05-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$38.46
P/E Ratio
★ N/A
$19.77
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$1.50
52 Week High
$19.40
$10.60

Technical Indicators

Market Signals
Indicator
TENX
ANTA
Relative Strength Index (RSI) 35.62 54.25
Support Level $1.34 $2.12
Resistance Level $2.01 $4.19
Average True Range (ATR) 0.12 0.28
MACD 0.00 0.11
Stochastic Oscillator 6.25 90.13

Price Performance

Historical Comparison
TENX
ANTA

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ANTA Antalpha Platform Holding Company Ordinary Shares

Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.

Share on Social Networks: